Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
20.16
+0.23 (1.15%)
At close: Jan 16, 2026, 4:00 PM EST
20.46
+0.30 (1.51%)
After-hours: Jan 16, 2026, 7:19 PM EST
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.08 billion as of January 16, 2026. Its market cap has increased by 216.18% in one year.
Market Cap
1.08B
Enterprise Value
792.09M
1-Year Change
216.18%
Ranking
Category
Stock Price
$20.16
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.08B, an increase of 59.97%. That is a compound annual growth rate of 41.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.08B | -44.48% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |